On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

MMACHC

metabolism of cobalamin associated C

The MMACHC gene provides instructions for a protein critical in the body's processing of vitamin B12 (cobalamin), essential for metabolic pathways. The MMACHC gene encodes a protein integral to vitamin B12 metabolism, facilitating its conversion into vital cofactors.

Chromosome 1p34.1 Autosomal recessive HGNC:24525 Tier C
MMACHC 1p34.1 p arm q arm 1

MMACHC is located on the short (p) arm of chromosome 1, at band 1p34.1. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 1 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The MMACHC gene, also known as methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria, plays a key role in human metabolism. It provides the genetic blueprint for a protein that is essential for the proper processing of vitamin B12, or cobalamin. This processing is vital for converting vitamin B12 into active forms known as cofactors, which are then used by various enzymes to support critical bodily functions.

Disruptions in the function of the MMACHC gene can lead to metabolic disorders, highlighting its importance in maintaining overall health.

What the gene does

The MMACHC gene directs the production of a protein responsible for converting vitamin B12 into two crucial molecules: adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl). AdoCbl acts as a cofactor for methylmalonyl CoA mutase, an enzyme that facilitates the breakdown of specific amino acids, fatty acids, and cholesterol. Meanwhile, MeCbl is a cofactor for methionine synthase, an enzyme involved in converting homocysteine to methionine, an amino acid used in protein synthesis and the creation of other essential compounds.

Research indicates that the MMACHC protein is involved in preparing different forms of vitamin B12 for conversion into these cofactors. The MMACHC protein interacts with another protein, MMADHC, to transport processed vitamin B12 to specific cellular locations: mitochondria for AdoCbl function and the cytoplasm for MeCbl function. Subsequent reactions then finalise the conversion of vitamin B12 into its active AdoCbl or MeCbl forms.

Video: Genetics 101

Chromosome location

The MMACHC gene is situated on the short arm of chromosome 1, at position 1p34.1. This genomic location specifies its precise address within the human genome.

Protein structure

The MMACHC protein consists of 282 amino acids. While detailed domain architecture has not been fully characterised, a disordered region has been identified, spanning amino acids 234-282. This disordered segment may be important for the protein's flexibility and interactions with other molecules.

Key variants

Variations within the MMACHC gene can alter the protein's structure and function, impacting its ability to process vitamin B12 effectively. These genetic changes can range from single base pair substitutions to larger deletions or duplications. The nature and location of these variants often dictate the severity of their impact on protein function and, consequently, on an individual's health.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for MMACHC.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.126_141del
Deletion
p.Leu43fs Pathogenic ★★☆☆ Cobalamin C disease
c.151_152del
Deletion
p.Leu51fs Pathogenic/Likely pathogenic ★★☆☆ Cobalamin C disease
c.191_195del
Deletion
p.Lys64fs Pathogenic/Likely pathogenic ★★☆☆ Cobalamin C disease
c.228_231del
Microsatellite
p.Asp77fs Pathogenic ★★☆☆ Cobalamin C disease
c.241C>T
single nucleotide variant
p.Gln81Ter Pathogenic/Likely pathogenic ★★☆☆ Cobalamin C disease
c.271_272AG[2]
Microsatellite
p.Ser93fs Pathogenic/Likely pathogenic ★★☆☆ Cobalamin C disease
c.271_272insC
Insertion
p.Arg91fs Pathogenic/Likely pathogenic ★★☆☆ Cobalamin C disease
c.281_290del
Deletion
p.Leu94fs Pathogenic/Likely pathogenic ★★☆☆ Cobalamin C disease
c.365A>T
single nucleotide variant
p.His122Leu Pathogenic ★★☆☆ Cobalamin C disease
c.430-2A>G
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Cobalamin C disease

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Variants in the MMACHC gene are associated with methylmalonic acidaemia with homocystinuria, cblC type. This is the most common form of a disorder characterised by developmental delay, eye abnormalities, neurological issues, and blood disorders. These gene variants result in a dysfunctional MMACHC protein, impairing the body's ability to properly metabolise vitamin B12.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

Inheritance pattern

Conditions caused by pathogenic MMACHC variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous MMACHC carrier status across ancestry groups?

UK clinical status

The MMACHC gene is included in several panels within the UK's NHS Genomic Medicine Service, as listed in PanelApp. It is green-rated for various conditions, including 'Ataxia and cerebellar anomalies - childhood onset', 'Atypical haemolytic uraemic syndrome', 'DDG2P', 'Early onset or syndromic epilepsy', 'Foetal anomalies', 'Hereditary ataxia', 'Hereditary ataxia, adult onset', 'Hereditary neuropathy', 'Hereditary neuropathy or pain disorder', 'Intellectual disability', 'Likely inborn error of metabolism', 'Retinal disorders', and 'Undiagnosed metabolic disorders'. This indicates that variants in MMACHC are considered clinically actionable for these conditions in the UK healthcare system.

Frequently asked questions

What is the primary role of the MMACHC gene?

The MMACHC gene is crucial for processing vitamin B12 (cobalamin) into its active forms, adenosylcobalamin and methylcobalamin, which are essential cofactors for various enzymes involved in metabolism.

What condition is associated with MMACHC gene variants?

Variants in the MMACHC gene are associated with methylmalonic acidaemia with homocystinuria, cblC type, a metabolic disorder affecting development, vision, neurological function, and blood.

How does the MMACHC protein facilitate vitamin B12 metabolism?

The MMACHC protein helps prepare vitamin B12 for conversion into cofactors and works with the MMADHC protein to transport processed vitamin B12 to specific cellular locations where these cofactors function.

References

  1. Froese DS, Kopec J, Fitzpatrick F. Structural Insights into the MMACHC-MMADHC Protein Complex Involved in Vitamin B12 Trafficking. The Journal of biological chemistry. 2015. PMID: 26483544
  2. Lerner-Ellis JP, Anastasio N, Liu J. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Human mutation. 2009. PMID: 19370762
  3. Hannibal L, Kim J, Brasch NE. Processing of alkylcobalamins in mammalian cells: A role for the MMACHC (cblC) gene product. Molecular genetics and metabolism. 2009. PMID: 19447654
  4. Kim J, Gherasim C, Banerjee R. Decyanation of vitamin B12 by a trafficking chaperone. Proceedings of the National Academy of Sciences of the United States of America. 2008. PMID: 18779575
  5. Lerner-Ellis JP, Tirone JC, Pawelek PD. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nature genetics. 2006. PMID: 16311595
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .